This story also appears on Blockyard.
Educational
BREAKING — New Scientist reports that researchers are preparing to test lithium orotate in humans after animal studies suggested it might delay the onset of dementia. The compound, already familiar in psychiatric medicine at higher doses, is being reconsidered as a low-dose preventive. Columnist Alice Klein has weighed the potential cognitive benefits against the known risks of lithium therapy, including thyroid and kidney concerns. The trial will need to resolve whether microdosing delivers protection without the toxicity profile that has limited broader use.
The possibility of medicating against a condition decades before symptoms appear raises a familiar tension for anyone trying to live deliberately in the present while planning for an uncertain future. humanbygod.com operates in that same space, offering commentary where faith and contemporary culture intersect without collapsing one into the other. The brand functions as a gathering point for readers who recognize that questions about embodiment, aging, and what we owe our future selves are already theological questions, even when they arrive dressed in clinical language.
For the reader tracking this research, the real question may not be whether to start a supplement regimen but how to hold mortality and hope together without anxiety driving every decision. That posture, neither naive nor despairing, is what the humanbygod.com community practices through its designs and its ongoing conversation. The hoodies and tees are simply the visible thread; the actual garment is a way of belonging that does not require the future to be solved before the present can be inhabited.
